<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05005650</url>
  </required_header>
  <id_info>
    <org_study_id>SDLNOC</org_study_id>
    <nct_id>NCT05005650</nct_id>
  </id_info>
  <brief_title>Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy</brief_title>
  <acronym>SDLNOC</acronym>
  <official_title>Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy on Stage IVB Ovarian Cancer With Supradiaphragmatic Lymph Node Metastasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in&#xD;
      stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Progression-free survival</measure>
    <time_frame>From date of treatment until the date of first documented progression or date of death (by any cause, in the absence of disease progression) whichever came first, assessed up to 120 months</time_frame>
    <description>the time interval from the treatment start date to disease recurrence or progression date</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>From the date of treatment start date until death due to any cause, assessed up to 120 months</time_frame>
    <description>the time interval from the treatment start date to death or end of study date</description>
  </secondary_outcome>
  <enrollment type="Anticipated">121</enrollment>
  <condition>Ovarian Cancer Stage IV</condition>
  <condition>Lymph Node Metastases</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>debulking surgery</intervention_name>
    <description>debulking surgery as primary debulking surgery or interval debulking surgery</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients underwent treatment at University Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Histologically diagnosed ovarian, fallopian tubal, primary peritoneal cancer&#xD;
&#xD;
          -  Patients suspected of metastatic lymph nodes in the cardiophrenic, internal mammary,&#xD;
             and/or supraclavicular lymph node by CT (size larger than 5mm)&#xD;
&#xD;
          -  Patients clinically diagnosed FIGO stage IVB ovarian, fallopian tubal, primary&#xD;
             peritoneal cancer&#xD;
&#xD;
          -  Patients underwent debulking surgery (primary debulking surgery or interval debulking&#xD;
             surgery) at Seoul National University Hospital from January 2010 to January 2020&#xD;
&#xD;
          -  Patients age 18-90&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Borderline or benign ovarian disease&#xD;
&#xD;
          -  Patient didn't undergo debulking surgery&#xD;
&#xD;
          -  Non-epithelial ovarian cancer&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hee Seung Kim, Pf</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Park Soo Jin, Dr</last_name>
    <phone>82-2-2072-0897</phone>
    <email>soojin.mdpark@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>시/도/주</state>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee Seung Kim</last_name>
      <phone>020724863</phone>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Randall LM, Pothuri B. The genetic prediction of risk for gynecologic cancers. Gynecol Oncol. 2016 Apr;141(1):10-6. doi: 10.1016/j.ygyno.2016.03.007. Review.</citation>
    <PMID>27016223</PMID>
  </reference>
  <reference>
    <citation>Ataseven B, Grimm C, Harter P, Heitz F, Traut A, Prader S, du Bois A. Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV. Gynecol Oncol. 2016 Feb;140(2):215-20. doi: 10.1016/j.ygyno.2015.12.007. Epub 2015 Dec 12.</citation>
    <PMID>26691222</PMID>
  </reference>
  <reference>
    <citation>Lim MC, Lee HS, Jung DC, Choi JY, Seo SS, Park SY. Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery. Ann Surg Oncol. 2009 Jul;16(7):1990-6. doi: 10.1245/s10434-009-0486-5. Epub 2009 Apr 30.</citation>
    <PMID>19408045</PMID>
  </reference>
  <reference>
    <citation>Yoo HJ, Lim MC, Song YJ, Jung YS, Kim SH, Yoo CW, Park SY. Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer. Gynecol Oncol. 2013 May;129(2):341-5. doi: 10.1016/j.ygyno.2012.12.023. Epub 2013 Jan 3.</citation>
    <PMID>23290988</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 6, 2021</study_first_submitted>
  <study_first_submitted_qc>August 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2021</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee Seung Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>internal mammary lymph node</keyword>
  <keyword>supraclavicular lymph node</keyword>
  <keyword>cardiophrenic lymph node</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ovarian Epithelial</mesh_term>
    <mesh_term>Lymphatic Metastasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

